Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100149912 | 10014991 | 2 | F | 20140222 | 20140617 | 20140317 | 20140630 | EXP | US-ACTELION-A-US2014-95834 | ACTELION | 76.00 | YR | M | Y | 0.00000 | 20140630 | N | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100149912 | 10014991 | 1 | PS | TRACLEER | 1 | ORAL | UNK | D | 21290 | TABLET | |||||||||
| 100149912 | 10014991 | 2 | C | COUMADIN | 1 | U | 0 | ||||||||||||
| 100149912 | 10014991 | 3 | C | TYVASO | 1 | U | 0 | ||||||||||||
| 100149912 | 10014991 | 4 | C | RIOCIGUAT | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100149912 | 10014991 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100149912 | 10014991 | OT |
| 100149912 | 10014991 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100149912 | 10014991 | Cardiac operation | |
| 100149912 | 10014991 | Post procedural haematoma | |
| 100149912 | 10014991 | Pulmonary thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |